Cipher Pharmaceuticals (TSE:CPH) has released an update.
Cipher Pharmaceuticals Inc. has announced the release of its Q2 2024 financial results after market close on August 8, 2024, followed by a conference call on August 9 to discuss the company’s performance and corporate developments. The company, known for its dermatology-focused portfolio, will engage with investors and analysts during this call.
For further insights into TSE:CPH stock, check out TipRanks’ Stock Analysis page.
